Extensions for Using Data Elements from FHIR DSTU2 in FHIR R4B
0.1.0 - STU
Extensions for Using Data Elements from FHIR DSTU2 in FHIR R4B
0.1.0 - STU
Extensions for Using Data Elements from FHIR DSTU2 in FHIR R4B - Downloaded Version null See the Directory of published versions
| Page standards status: Trial-use | Maturity Level: 0 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="v3-substanceAdminSubstitution"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem v3-substanceAdminSubstitution</b></p><a name="v3-substanceAdminSubstitution"> </a><a name="hcv3-substanceAdminSubstitution"> </a><p><b>Properties</b></p><p><b>This code system defines the following properties for its concepts</b></p><table class="grid"><tr><td><b>Name</b></td><td><b>Code</b></td><td><b>URI</b></td><td><b>Type</b></td></tr><tr><td>status</td><td>status</td><td>http://hl7.org/fhir/concept-properties#status</td><td>code</td></tr><tr><td>Inactive</td><td>inactive</td><td>http://hl7.org/fhir/concept-properties#inactive</td><td>boolean</td></tr><tr><td>effectiveDate</td><td>effectiveDate</td><td>http://hl7.org/fhir/concept-properties#effectiveDate</td><td>dateTime</td></tr><tr><td>deprecationDate</td><td>deprecationDate</td><td>http://hl7.org/fhir/concept-properties#deprecationDate</td><td>dateTime</td></tr><tr><td>retirementDate</td><td>retirementDate</td><td>http://hl7.org/fhir/concept-properties#retirementDate</td><td>dateTime</td></tr><tr><td>Not Selectable</td><td>notSelectable</td><td>http://hl7.org/fhir/concept-properties#notSelectable</td><td>boolean</td></tr><tr><td>Parent</td><td>parent</td><td>http://hl7.org/fhir/concept-properties#parent</td><td>code</td></tr><tr><td>Child</td><td>child</td><td>http://hl7.org/fhir/concept-properties#child</td><td>code</td></tr><tr><td>partOf</td><td>partOf</td><td>http://hl7.org/fhir/concept-properties#partOf</td><td>code</td></tr><tr><td>synonym</td><td>synonym</td><td>http://hl7.org/fhir/concept-properties#synonym</td><td>code</td></tr><tr><td>comment</td><td>comment</td><td>http://hl7.org/fhir/concept-properties#comment</td><td>string</td></tr><tr><td>itemWeight</td><td>itemWeight</td><td>http://hl7.org/fhir/concept-properties#itemWeight</td><td>decimal</td></tr></table><p><b>Concepts</b></p><p>This case-sensitive code system <code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code> defines the following codes in an undefined hierarchy:</p><table class="codes"><tr><td><b>Lvl</b></td><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td><td><b>Not Selectable</b></td></tr><tr><td>1</td><td style="white-space:nowrap">_ActSubstanceAdminSubstitutionCode<a name="v3-substanceAdminSubstitution-_ActSubstanceAdminSubstitutionCode"> </a></td><td>ActSubstanceAdminSubstitutionCode</td><td>Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.</td><td>true</td></tr><tr><td>2</td><td style="white-space:nowrap"> E<a name="v3-substanceAdminSubstitution-E"> </a></td><td>equivalent</td><td>Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.</td><td>false</td></tr><tr><td>3</td><td style="white-space:nowrap"> EC<a name="v3-substanceAdminSubstitution-EC"> </a></td><td>equivalent composition</td><td>Description: Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril</td><td>false</td></tr><tr><td>4</td><td style="white-space:nowrap"> BC<a name="v3-substanceAdminSubstitution-BC"> </a></td><td>brand composition</td><td>Description: Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven</td><td>false</td></tr><tr><td>4</td><td style="white-space:nowrap"> G<a name="v3-substanceAdminSubstitution-G"> </a></td><td>generic composition</td><td>Description: Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)</td><td>false</td></tr><tr><td>3</td><td style="white-space:nowrap"> TE<a name="v3-substanceAdminSubstitution-TE"> </a></td><td>therapeutic alternative</td><td>Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet</td><td>false</td></tr><tr><td>4</td><td style="white-space:nowrap"> TB<a name="v3-substanceAdminSubstitution-TB"> </a></td><td>therapeutic brand</td><td>Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics > Examples: Zantac for Tagamet</td><td>false</td></tr><tr><td>4</td><td style="white-space:nowrap"> TG<a name="v3-substanceAdminSubstitution-TG"> </a></td><td>therapeutic generic</td><td>Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands > Examples: Ranitidine for cimetidine</td><td>false</td></tr><tr><td>2</td><td style="white-space:nowrap"> F<a name="v3-substanceAdminSubstitution-F"> </a></td><td>formulary</td><td>Description: This substitution was performed or is permitted based on formulary guidelines.</td><td>false</td></tr><tr><td>2</td><td style="white-space:nowrap"> N<a name="v3-substanceAdminSubstitution-N"> </a></td><td>none</td><td>No substitution occurred or is permitted.</td><td>false</td></tr></table></div>
</text>
<extension url="http://hl7.org/fhir/StructureDefinition/valueset-oid">
<valueUri value="urn:oid:2.16.840.1.113883.5.1070"/>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/package-source">
<extension url="packageId">
<valueId value="hl7.fhir.uv.xver-r2.r4b"/>
</extension>
<extension url="version">
<valueString value="0.1.0"/>
</extension>
<extension url="uri">
<valueUri
value="http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r4b"/>
</extension>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
<valueCode value="fhir"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
<valueInteger value="0">
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom">
<valueCanonical
value="http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r4b"/>
</extension>
</valueInteger>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status">
<valueCode value="trial-use">
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom">
<valueCanonical
value="http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r4b"/>
</extension>
</valueCode>
</extension>
<url value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<name value="v3-substanceAdminSubstitution"/>
<status value="draft"/>
<date value="2026-03-20T11:13:27+11:00"/>
<publisher value="FHIR Infrastructure"/>
<contact>
<name value="FHIR Infrastructure"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/fiwg"/>
</telecom>
</contact>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="001"/>
<display value="World"/>
</coding>
</jurisdiction>
<caseSensitive value="true"/>
<content value="complete"/>
<property>
<code value="status"/>
<uri value="http://hl7.org/fhir/concept-properties#status"/>
<type value="code"/>
</property>
<property>
<code value="inactive"/>
<uri value="http://hl7.org/fhir/concept-properties#inactive"/>
<type value="boolean"/>
</property>
<property>
<code value="effectiveDate"/>
<uri value="http://hl7.org/fhir/concept-properties#effectiveDate"/>
<type value="dateTime"/>
</property>
<property>
<code value="deprecationDate"/>
<uri value="http://hl7.org/fhir/concept-properties#deprecationDate"/>
<type value="dateTime"/>
</property>
<property>
<code value="retirementDate"/>
<uri value="http://hl7.org/fhir/concept-properties#retirementDate"/>
<type value="dateTime"/>
</property>
<property>
<code value="notSelectable"/>
<uri value="http://hl7.org/fhir/concept-properties#notSelectable"/>
<type value="boolean"/>
</property>
<property>
<code value="parent"/>
<uri value="http://hl7.org/fhir/concept-properties#parent"/>
<type value="code"/>
</property>
<property>
<code value="child"/>
<uri value="http://hl7.org/fhir/concept-properties#child"/>
<type value="code"/>
</property>
<property>
<code value="partOf"/>
<uri value="http://hl7.org/fhir/concept-properties#partOf"/>
<type value="code"/>
</property>
<property>
<code value="synonym"/>
<uri value="http://hl7.org/fhir/concept-properties#synonym"/>
<type value="code"/>
</property>
<property>
<code value="comment"/>
<uri value="http://hl7.org/fhir/concept-properties#comment"/>
<type value="string"/>
</property>
<property>
<code value="itemWeight"/>
<uri value="http://hl7.org/fhir/concept-properties#itemWeight"/>
<type value="decimal"/>
</property>
<concept>
<code value="_ActSubstanceAdminSubstitutionCode"/>
<display value="ActSubstanceAdminSubstitutionCode"/>
<definition
value="Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects."/>
<property>
<code value="notSelectable"/>
<valueBoolean value="true"/>
</property>
<concept>
<code value="E"/>
<display value="equivalent"/>
<definition
value="Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product."/>
<property>
<code value="notSelectable"/>
<valueBoolean value="false"/>
</property>
<concept>
<code value="EC"/>
<display value="equivalent composition"/>
<definition
value="Description: Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril"/>
<property>
<code value="notSelectable"/>
<valueBoolean value="false"/>
</property>
<concept>
<code value="BC"/>
<display value="brand composition"/>
<definition
value="Description: Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven"/>
<property>
<code value="notSelectable"/>
<valueBoolean value="false"/>
</property>
</concept>
<concept>
<code value="G"/>
<display value="generic composition"/>
<definition
value="Description: Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)"/>
<property>
<code value="notSelectable"/>
<valueBoolean value="false"/>
</property>
</concept>
</concept>
<concept>
<code value="TE"/>
<display value="therapeutic alternative"/>
<definition
value="Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet"/>
<property>
<code value="notSelectable"/>
<valueBoolean value="false"/>
</property>
<concept>
<code value="TB"/>
<display value="therapeutic brand"/>
<definition
value="Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics > Examples: Zantac for Tagamet"/>
<property>
<code value="notSelectable"/>
<valueBoolean value="false"/>
</property>
</concept>
<concept>
<code value="TG"/>
<display value="therapeutic generic"/>
<definition
value="Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands > Examples: Ranitidine for cimetidine"/>
<property>
<code value="notSelectable"/>
<valueBoolean value="false"/>
</property>
</concept>
</concept>
</concept>
<concept>
<code value="F"/>
<display value="formulary"/>
<definition
value="Description: This substitution was performed or is permitted based on formulary guidelines."/>
<property>
<code value="notSelectable"/>
<valueBoolean value="false"/>
</property>
</concept>
<concept>
<code value="N"/>
<display value="none"/>
<definition value="No substitution occurred or is permitted."/>
<property>
<code value="notSelectable"/>
<valueBoolean value="false"/>
</property>
</concept>
</concept>
</CodeSystem>
IG © 2025+ FHIR Infrastructure. Package hl7.fhir.uv.xver-r2.r4b#0.1.0 based on FHIR 4.3.0. Generated 2026-03-20
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change